These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4591487)

  • 1. Clinical pharmacology of oral cephradine.
    Zaki A; Schreiber EC; Weliky I; Knill JR; Hubsher JA
    J Clin Pharmacol; 1974; 14(2):118-26. PubMed ID: 4591487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of cephalexin and cephradine in surgical patients].
    Iakovlev VP; Marshak AM; Klimova VS; Lur'e LA
    Antibiotiki; 1977 Aug; 22(8):739-42. PubMed ID: 334053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral cephalosporins: cephradine cephalexin.
    Finkelstein E; Quintiliani R; Lee R; Bracci A; Nightingale CH
    J Pharm Sci; 1978 Oct; 67(10):1447-50. PubMed ID: 702300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lower dose regimen for cephradine capsules in the treatment of urinary tract infections.
    Brosof AB; Spitzer TQ
    Clin Ther; 1980; 3(1):3-8. PubMed ID: 6996816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-day therapy with cephradine capsules, 500 mg BID, for the treatment of acute, uncomplicated urinary tract infections.
    Brosof AB
    Clin Ther; 1980; 3(4):285-91. PubMed ID: 7023676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 2% procaine hydrochloride solution on the bioavailability of cephradine after intramuscular injection.
    Vukovich RA; Sugerman AA; Fields LA
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):711-9. PubMed ID: 812649
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative efficacy and safety of cephradine and cephalexin in children.
    Mouallem R
    J Int Med Res; 1976; 4(4):265-71. PubMed ID: 799997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.
    Ginsburg CM
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():27-31. PubMed ID: 7142090
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of high-dose oral cephalosporins.
    Chow M; Quintiliani R; Cunha BA; Thompson M; Finkelstein E; Nightingale CH
    J Clin Pharmacol; 1979 Apr; 19(4):185-94. PubMed ID: 438352
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative determination of cephalexin in cephradine by NMR spectroscopy.
    Warren RJ; Zarembo JE; Staiger DB; Post A
    J Pharm Sci; 1978 Oct; 67(10):1481-2. PubMed ID: 702311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice daily treatment of pneumonia with cephradine.
    Caloza DL; Bernfeld GE
    J Maine Med Assoc; 1977 May; 68(5):152-5. PubMed ID: 325160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of cephalexin and cephradine distribution in the body of rats].
    Klimova VS
    Antibiotiki; 1979 Oct; 24(10):764-7. PubMed ID: 496419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the intramuscular absorption and bioavailability of cephradine.
    Vukovich RA; Brannick LJ; Sugerman AA; Neiss ES
    Clin Pharmacol Ther; 1975 Aug; 18(2):215-20. PubMed ID: 233954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Discontinuous" antibiotic therapy for urinary tract infections.
    Caloza DL; Fields LA; Bernfeld GE
    Scand J Infect Dis; 1978; 10(1):75-8. PubMed ID: 345423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cephradine given intravenously with and without probenecid.
    Roberts DH; Kendall MJ; Jack DB; Welling PG
    Br J Clin Pharmacol; 1981 Jun; 11(6):561-4. PubMed ID: 7272172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of a new cephalosporin for oral use in dermatology].
    Goitre M; Bedello PG
    G Ital Dermatol Venereol; 1982; 117(4):XLIX-LIV. PubMed ID: 6764911
    [No Abstract]   [Full Text] [Related]  

  • 19. The determination of cephradine and cephalexin by reverse phase high-performance liquid chromatography.
    Carrol MA; White ER; Jancsik Z; Zarembo JE
    J Antibiot (Tokyo); 1977 May; 30(5):397-403. PubMed ID: 885797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probenecid: an unexplained effect on cephalosporin pharmacology.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Br J Clin Pharmacol; 1979 Nov; 8(5):491-5. PubMed ID: 508557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.